Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-8
Closed -$605 835
2026
Q1
$605 Hold
8
﹤0.01% 919
2025
Q4
$596 Hold
8
﹤0.01% 857
2025
Q3
$540 Hold
8
﹤0.01% 845
2025
Q2
$522 Buy
+8
New +$480 ﹤0.01% 839
2025
Q1
Sell
-114
Closed -$8.22K 858
2024
Q4
$8.22K Hold
114
﹤0.01% 613
2024
Q3
$9.29K Buy
+114
New +$9.12K ﹤0.01% 602
2023
Q1
Sell
-5
Closed -$374 699
2022
Q4
$374 Hold
5
﹤0.01% 718
2022
Q3
$0 Hold
5
﹤0.01% 720
2022
Q2
$0 Hold
5
﹤0.01% 713
2022
Q1
$0 Hold
5
﹤0.01% 740
2021
Q4
$0 Buy
+5
New +$368 ﹤0.01% 689

Other funds holding HOLX

Addison Advisors's HOLX Position: Q2 2026 in Review

Addison Advisors sold out of Hologic (HOLX) in Q2 2026, closing a stake of 8 shares — an estimated $605 sold.

Addison Advisors first reported a position in HOLX in Q4 2021 and held it in 11 quarters. The position peaked at $9.29K in Q3 2024. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.

  • Addison Advisors reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
  • Addison Advisors sold 8 Hologic shares in Q2 2026, an estimated $605.
  • Addison Advisors first reported a position in Hologic in Q4 2021 and held it in 11 quarters.
  • Addison Advisors's Hologic position peaked at $9.29K in Q3 2024.
  • 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.

Based on Addison Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.